temperature for 20 min at 400 g to remove fine debris, erythrocytes, and dead cells . After washing with PBS containing I% FCS (PBS I% FCS), the LNG were adjusted to 25 x 106 cells/ml and 0 .4 ml of this suspension was injected into the lateral tail vein of a recipient mouse. At this point, the LNC viability was typically >96% .
Labeling Donor Cells with FIX. Generally following Butcher and Weissman (21) , cells prepared as above were resuspended to a concentration of 50 x 106 cells/ml of 0 .9% BSA in PBS and a FITC stock solution (600 tug/ml in PBS) was added to make a final concentration of 30 gg/ml. After a 20-min incubation at 37'C in a water bath placed in an incubator with a 10% C02/air atmosphere, the reaction was stopped by addition of 5 ml medium and centrifugation through 3 ml of 6% BSA in PBS, followed by washing with PBS 1% FCS .
Analysis and Separation of Donor Cells Retrieved from the Recipient. LNC were isolated from recipients of an injection of 1-2 x 10' FITC-labeled cells. The labeled cells were identified and could be sorted apart from the host cells using a Coulter Epics V flow cytometer. Dead cells were eliminated based on forward angle light scatter and analysis was typically based on 3 x 104 to 1 x 105 events . Flow cytometric analysis of labeled populations showed that 100% of the cells were initially brightly labeled.
The magnitude of fluorescence of cells, retrieved from lymph nodes or spleens of intravenously injected mice, though remaining bright and easily detectable, decreased rapidly during the first few hours, then remained relatively constant, decreasing very slowly over the following days (N5-10% per day). Examination of labeled cells by fluorescence microscopy showed a correlation between the rapid loss of fluorescence and an altered pattern of staining, which changed from bright rim fluorescence to a diffuse cytosolic fluorescence that included the nucleus of all cells (although initially fluorescence is absent in the nuclei) . In vitro cell mixing experiments between labeled and unlabeled cell populations showed no evidence for transfer of label between neighboring cells, supporting earlier in vivo findings by others (22) .
Generation of CTL and the Cytotoxicity Assay. A standard MLR was used to activate and expand reactive CTL within the responder LNC population . 3 x 104 responder B6 LNC were cultured for 5 d with 3 x 105 BDF, irradiated (2,000 rad) spleen cells in 96-well V-bottomed plates (Linbro; Flow Laboratories, Mississauga, Ontario), six replicates per group, then tested for the ability to kill "Cr-labeled BDF1 or D2 spleen cell Con A blasts, or "Cr-labeled P815 (H-2d) tumor targets, as previously described (23) . The specific cytolytic activity (23) of the experimental group was expressed as a fraction of the control (mean t 1 SD) within each experiment . The control response was determined using LNC responder cells isolated from identically treated mice that had received 10' fully syngeneic LNC in place of donor BDF, cells . The response against third-party BR was tested in each experiment to verify the specificity of a reduced response.
Limiting Dilution Analysis. The CTLp frequency within responder LNC populations was determined by limiting dilution analysis as previously described (23) . Briefly, 100, 300, 600, 1,000, or 3,000 responder cells were distributed into 30, 24, 24, 18, or 12 wells, respectively, in 96-well Vbottomed plates. Additionally, each well received 3 x 105 irradiated spleen cells, as stimulators, and an optimal concentration of growth and differentiation factors, typically 10% rat Con A supernatant containing 45 mM a-methyl mannoside. After 5 d of culture, 3,000 BDF,, D2, or BR "Cr-labeled spleen cell Con A blast targets were added to each well. The spontaneous release ranged from 11 to 15% of total releasable radioactivity. This method has been previously characterized as having the sensitivity to detect the killing of a clonal population of CTL, that have expanded from a single CTLp (23) . Each well was scored as either plus (having lyric activity) or minus (not having lyric activity), and a fit to single hit limiting dilution was tested . Subsequently, the relative frequency of CTLp in the experimental LNC population was calculated as afraction ofthe frequency of CTLp in the control populati Results Intravenous Administration of F, Cells Can Reduce the Parental Host Response. Fig . 1 demonstrates the response reduction induced by a single intravenous injection of cc when LNG from these mice were subsequently tested for their ability to generate CTL in vitro in a B6 anti-BDFi MLR . Significant Cytolytic activity of B6 LNC against BDFI spleen cells in a 5-d MLR. The response by cells taken from B6 mice at various times after the injection of 107 BDFI LNC is shown as a fraction of the response by cells taken from control B6 mice simultaneously injected with 107 B6 LNC.
reduction of the response was detected by 24 h after the injection, approached a maximal level by 48 h, and persisted for at least 11 wk . The response of the injected mice against third-party cells, from BR or C3H, was not altered (e .g ., see Fig. 2 ) . Thus, the reduction of the response was specific for those T cells carrying receptors that were reactive with allogeneic determinants carried on the surface of the injected BDFI lymph node cells. Note that FI cells were used as donor cells to avoid the potential complications of a graft-vs.-host reaction .
Analysis of the Fate of the Injected Cell Population. We sought a method to identify and, if desired, remove the injected FI cells before in vitro testing. It has been shown previously (22) that FITC-conjugated lymphoid cells appear to remain labeled and to recirculate normally when injected intravenously into mice . We found that FITC conjugation of BDFI cells did not alter their ability to specifically reduce the subsequent response of B6 recipients against D2 alloantigen (Fig . 2) . Priorconjugation of FITC to BDFI donor LNC does not alter the capacity to reduce the B6 anti BDFI response. B6 recipients were either not injected (i.e ., unmanipulated control) or injected with 10 1 unlabeled LNC or 10 7 FITC-labeled LNC from the indicated donors. The relative response to a third-party alloantigen(anti BlO.B R response) is shown in the right half of the figure . BDFI-FITC cells from the responder population did not alter the magnitude of the reduction detected in the MLR. Note that reanalysis of the sorted cells demonstrated that the fluorescent donor cells were typically reduced to 0.01% or less of the total population, indicating that no more than three fluorescent donor cells were added to each MLR (see Materials and Methods) .
We have considered three possible explanations for the above results: (a) Suppressor cells of recipient origin became activated in vivo and mediated suppression in vitro; (b) suppressor cells of donor (Ft) origin became activated in vivo, in the process losing their fluorescent label, and mediated suppression in vitro; (c) recipient CTL precursors became inactivated in vivo before the cells were placed in the MLR. To distinguish among these possibilities, we used limiting dilution analysis to measure the frequency of CTLp reactive to BDFI cells in BDFt-injected and control B6-injected mice. Fig. 7 shows that the reduction in the magnitude of the MLR response in Fl-injected mice at varying times after injection was reflected by an equivalent, proportional decrease in the CTLp frequency. This suggests that response reduction is entirely the result of functional deletion of CTLp in vivo and not due to the induction of suppressor cells of either recipient or donor origin in vitro.
As a further test for the presence of suppressor cells acting in vitro, we measured the frequency of CTLp in an equal mixture of cells from control and Fl-injected mice on the assumption that any suppressor cells present should have an effect on the CTLp of both populations. The measured CTLp frequency was equivalent to The responses of lymphocytes recirculating through lymph node and spleen are reduced equally by exposure to semiallogeneic cells. FITC-labeled B6 LNC were injected intravenously into syngeneic B6 recipients (day -5). One day later (day -4), the mice were further injected with either 107 BDF, or 107 B6 LNC. 4 d later (day 0), FITC-labeled cells were recovered by cell sorting from both lymph node and spleen of each group and tested for their ability to generate CTL as indicated. Reanalysis of 104 sorted cells indicated an enrichment to 92-96% fluorescence positive cells for LNC, and 76-78% for spleen cells. Removal of the FITC-labeled resident BDFI LNG from the B6 responder cell population before the MLR does not reverse reduction of cytolytic activity. 
LNC from these mice and various controls (see below) were collected 6 d later and cultured in anti-BDFI (groups A-F) and anti-B10 .BR MLR cultures (groups A'-E') . Table entries are cytotoxic activity (mean of six replicates t 1 SD) after 5 d of culture shown as a fraction of the untreated control .
In groups A and A', animals were injected with 1 .4 x 106 , 1 .6 x 106 , 1 .9 x 10 6 , or 2 .0 x 10 6 recovered labeled cells in Exps . 1-4, respectively . In control groups E and E', mice were injected with matching numbers of freshly collected BDFI LNC . Control group F is the response of LNC from a group of primary recipient mice tested in the MLR cultures at the same time as the secondary recipients, i .e ., 12 d after injection of BDFI-FITC LNC . In Exp . 3, 2 .5 x 10 7 cells were injected . Flow cytometric analysis of the injected cells showed that 4-6 x 105 labeled cells were included in the injected cell population .
conjugated BDFI LNC could be used to induce response reduction in a second B6 recipient and, if so, which cells. B6 mice were injected with 1.5 x 10' FITCconjugated BDFI LNG . 6 d later a cell suspension was prepared from lymph nodes and sorted into fluorescent and nonfluorescent fractions, wich were then injected intravenously into other B6 mice. 6 d later LNC from these mice were tested for their ability to respond against BDFI and third-party stimulators. Mice injected with the fluorescent fraction (containing Fl cells that retained their label) showed specific response reduction (Table I , group A) ; mice injected with the nonfluorescent fraction (containing host B6 cells and any injected F1 cells that may have lost their label) showed a normal response (Table 1 , groups B and C). All groups showed a near normal response against third-party B10.BR stimulator cells (Table I , bottom section).
Discussion Our experiments lead to the conclusion that lymphoid cells taken from a parental (B6) mouse injected 1-8 d previously with BDFI lymphoid cells, and subsequently tested in an in vitro MLR, have been functionally deleted ofCTLp capable of recognizing the injected cells before being put in the MLR (Fig . 7) . This functional deletion appears to apply to the whole recirculating lymphocyte pool (Fig . 5) . It cannot be reversed by addition of an IL-2-containing supernatant, as equivalent reduction was seen in the limiting dilution assay measurements, where such a supernatant was added (Fig . 7 b) , and in bulk culture measurements or cytolytic activity, where supernatant was not added (Fig. 7 a) . Several lines of evidence suggest that functional deletion is not the result of induction in vivo of either host or donor antigen-specific (11) or antiidiotypic suppressor cells (10) that act during the in vitro culture period . Thus, if there were suppressor cells induced that acted in vitro, a mixture of lymph node cells prepared from parental controls and Fi-injected animals should produce a response less than the sum of the separate responses. However, the frequency of CTLp activated in such a mixture was equal to the sum of that observed in the separate populations (Fig . 7 b) . Further evidence against a role for suppressor cells was obtained in cell sorting experiments. Thus, when response reduction was induced by injection of FITC-labeled F1 cells, the same response reduction was observed in vitro whether or not labeled F1 cells were removed before in vitro culture (Fig. 6) . Here, suppressor cells, if present, must either be F1 cells that have lost their label or host cells. However, if instead of being put into MLR culture, the labeled and unlabeled fractions were transferred into new recipients, only the labeled cells could induce response reduction in the new recipient (Table I) . Thus, the labeled F1 cells retained the ability to induce response reduction, perhaps, as discussed below, by producing a functional deletion of host CTL precursors that recognize them .
It is important to note that these data do not rule out the possibility that suppressor cells, of either host or donor origin, are induced at later times (i.e ., later than day 8) and we are currently investigating these possibilities.
Sano et al . (24) have shown that intravenously administered allogeneic spleen cells, previously treated with neuraminidase, can lead to reduction in the anti-allo-delayedtype hypersensitivity (DTH) response, although untreated spleen cells have little effect . They argue that the neuraminidase-treated allogeneic donor cells concentrate in the liver, subsequently attracting circulating reactive T cells involved in the DTH response . Through an unknown mechanism, these events lead to long-term removal of effector precursor cells from the circulation . In contrast, we found that injection of neuraminidase-treated F1 LNC was less effective at inducing CTL response reduction than an injection of untreated control Fi LNC (data not shown), and we conclude that CTL precursor cells are not affected by the mechanism studied by Sano et al . Note that DTH reactions primarily involve class II MHC, whereas CTL reactions primarily involve class I MHC. A veto cell is a cell that can inactivate CTLp that recognize it (17) (18) (19) (20) , and can be thought of as a functionally deleting APC. The observations that we describe here could be explained by this mechanism. Thus, donor Fi cells would contain veto cells that, when recognized by host CTLp reactive against the foreign alloantigen, would lead to inactivation of these CTLp . Rammensee and colleagues have shown tht intravenous injection of allogeneic, T cell-containing lymphoid cells leads to an apparent functional deletion of both the host and the donor CTLp capable of recognizing each other (6, 8) . Our results generally confirm their findings and provide additional evidence to show that the mechanism responsible for response reduction is active in vivo, and is not due to induction of suppressor cells acting in vitro.
The veto phenomenon was first characterized by in vitro studies of the MLR, where it was shown that certain cells (CTL, but also other cells) have the ability to produce functional deletion of CTLp capable of recognizing determinants on their surface. It has been previously argued that a T cell that receives a specific signal (i .e., antigen in association with MHC) but then fails to receive all the necessary secondary signals will result in functional anergization of the T cell, rather than activation (25) . Consistent with this model, Jenkins et al . have recently shown that peptidic antigen presented by APCs previously treated with the crosslinking fixative ECDI (26, 27) , or by purified Ia incorporated into planar lipid membranes (28), fails to activate class II-restricted, antigen-specific helper T cell clones . Instead, this encounter can induce long-term unresponsiveness of these T cells to antigen presented subsequently by normal, untreated APC. The authors have argued that the T helper cell clones become unresponsive when a co-stimulatory factor fails to be delivered concomitantly with the antigen-specific, MHC-restricted signal (as opposed to active delivery of suppressor factors) . Support for this has come from the observation that addition of irradiated allogeneic B cells or macrophages to T cell clones cultured with ECDI-treated APCs and antigen can lead to their activation rather than anergization (27) , putatively resulting from delivery of a co-stimulatory factor. These findings contrast with the in vitro veto phenomenon affecting CTLp, since it has been observed that CTLp are most sensitive to veto 1-3 d after exposure to antigen (29) (30) (31) , and that mature CTL, (including CTL clones) are insensitive to inactivation by veto . Furthermore, the culture conditions used to detect activity of veto cells involve adding them to an MLR that includes irradiated allogeneic spleen cells as stimulators . To this point, no analogous co-stimulatory signals have been found that can overcome the activity of veto cells, or restore the response of inactivated CTLp . The mechanism of functional deletion in the studies we described here and in previous in vitro studies (17) (18) (19) (20) remains unclear and may not be the same in the two cases.
Although the precise molecular events may be distinct, both class I-restricted CTLp and class II-restricted helper T cells are apparently susceptible to functionally deleting antigen presentation . Analogously, B lymphocytes may be made unresponsive subsequent to interaction with specific antigen under special conditions (32, 33) . Delineation of the mechanisms involved in functionally deleting antigen presentation may be essential to understanding the regulation of specific immunity.
It would appear that a veto-like phenomenon could readily explain the mechanism of negative selection preventing the generation of autoreactive, pathogenic T cells during ontogeny in the thymus (34) (35) (36) (37) (38) . In addition, the evidence presented in this paper raises the possibility that these mechanisms may persist among mature populations in the periphery of the adult animal . Since current evidence suggests that processed self antigen may be presented on the cell surface in association with MHC (39, 40) , a peripheral veto mechanism increases the potential range of self antigens that may be presented to persisting autoreactive T cells and hence does not restrict the mechanism to privileged antigens presented solely in the thymic environment. It would then be intriguing to investigate the range of antigens that could be presented in a suppressive manner by such a system, the role of veto-like mechanisms in the downregulation of an immune response, and how such down regulating systems avoid interfering with effective immunity to infectious agents . Conversely, it would also be important to study if this system could be experimentally manipulated in order to selectively control or delete undesireable specificities from the T cell repertoire . This could be potentially useful for facilitating tissue allografting or for inactivating pathogenic T cells responsible for certain autoimmune diseases . Clinical precedent for this approach already exists, such as the observation that patients previously transfused with blood are more likely to accept a subsequent kidney transplant (41) . Animal studies indicate that this effect is optimized when the blood transfusion and subsequent graft are matched at MHC (3). We and others (7, 20) suggest that this might result from a veto mechanism similar to what we have discussed here.
Summary
It is well established that a single intravenous injection of Fl lymphocytes can rapidly and specifically reduce the ability of a parental recipient to generate CTL against donor alloantigens in a subsequent MLR. By fluorescently labeling the injected cells, we have been able to identify, and if desired, remove them in cell suspensions prepared from recipient spleen and lymph node. The injected cells, whether F1 or syngeneic, appeared to form part of the normal recirculating pool. Removal ofinjected Fl cells from responder lymph node or spleen cell suspensions had no effect on the response reduction observed in the 5-d in vitro MLR (typically 80% reduction for responder cells taken 2 d after injection of Fi cells) . When the frequency of CTL precursors (CTLp) was measured by limiting dilution, it was reduced to the same degree as the MLR response, implying that response reduction is due to a reduction in the number of activatable CTL in the responder cell suspension. An equal mixture of responder cells from treated (i.e., Fl injected) and control mice gave a measured CTLp frequency equivalent to the average of the separate frequencies, implying the absence of suppressor cells active in vitro. Labeled Fl cells recovered from a first recipient could be used to induce response reduction in a second recipient . The results are discussed in terms ofAPCs that functionally delete rather than stimulate CTLp that recognize them (i.e., a "veto mechanism") . These experiments appear to rule out a role for in vivo-induced suppressor cells up to 8 d after injection of semiallogeneic cells but do not address the question of whether they are induced at later times .
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